| Literature DB >> 22509419 |
Joan L Kenney1, A Paige Adams, Rodion Gorchakov, Grace Leal, Scott C Weaver.
Abstract
Venezuelan equine encephalitis (VEE) is a re-emerging, mosquito-borne viral disease with the potential to cause fatal encephalitis in both humans and equids. Recently, detection of endemic VEE caused by enzootic strains has escalated in Mexico, Peru, Bolivia, Colombia and Ecuador, emphasizing the importance of understanding the enzootic transmission cycle of the etiologic agent, VEE virus (VEEV). The majority of work examining the viral determinants of vector infection has been performed in the epizootic mosquito vector, Aedes (Ochlerotatus) taeniorhynchus. Based on the fundamental differences between the epizootic and enzootic cycles, we hypothesized that the virus-vector interaction of the enzootic cycle is fundamentally different from that of the epizootic model. We therefore examined the determinants for VEEV IE infection in the enzootic vector, Culex (Melanoconion) taeniopus, and determined the number and susceptibility of midgut epithelial cells initially infected and their distribution compared to the epizootic virus-vector interaction. Using chimeric viruses, we demonstrated that the determinants of infection for the enzootic vector are different than those observed for the epizootic vector. Similarly, we showed that, unlike A. taeniorhynchus infection with subtype IC VEEV, C. taeniopus does not have a limited subpopulation of midgut cells susceptible to subtype IE VEEV. These findings support the hypothesis that the enzootic VEEV relationship with C. taeniopus differs from the epizootic virus-vector interaction in that the determinants appear to be found in both the nonstructural and structural regions, and initial midgut infection is not limited to a small population of susceptible cells.Entities:
Mesh:
Year: 2012 PMID: 22509419 PMCID: PMC3317907 DOI: 10.1371/journal.pntd.0001606
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Schematic diagram of the virus strains utilized in this study.
(A) The two parental viruses included strains IE 68U201 and IAB Trinidad Donkey (TrD). (B) IAB/IE/IAB and IE/IAB/IE were designed with matching cis-acting elements, which corresponded to the nonstructural protein opening reading frame (ORF) of the chimera. (C) IAB/IE and IE/IAB were designed with mismatched cis-acting elements, where the 3′ UTR matched the strain used for the structural protein region of the chimera and the 5′ UTR matched the strain used for the nonstructural protein region of the chimera. Tth111I indicates the location in which the two chimeric fusion fragments were joined by PCR.
Figure 2Schematic diagram of the replicons.
(A) 68UGFP and (B) 68UCFP.
Primers used to generate chimeras.
| Name | Description | Sequence |
| IAB/IE F | Tth111I Fusion Forward (A/E) |
|
| IAB/IE R | Tth111I Fusion Reverse (A/E) |
|
| 7041 F IAB | Outer Joining Forward Primer (A/E) |
|
| 8312 R IE | Outer Joining Reverse Primer (A/E) |
|
| IE/IAB F | Tth111I Fusion Forward (E/A) |
|
| IE/IAB R | Tth111I Fusion Reverse (E/A) |
|
| 6509 F IE | Outer Joining Forward primer (E/A) |
|
| 8007 R IAB | Outer Joining Reverse primer (E/A) |
|
Figure 3Viral replication kinetics.
Comparison of two parental viruses IAB TrD and IE 68U201 and four chimeric viruses, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, at a multiplicity of infection (MOI) of 5 on Vero (A) and C6/36 (B) cells. Error bars represent the standard deviation of the means.
Virus infection and dissemination rates in C. taeniopus.
| Virus | BM Titer | Infection rate [# infected/total # fed (%)] | Disseminated rate [# disseminated/total # fed (%)] | Dissemination infection rate [# disseminated/# infected (%)] |
| IAB | 3.87 | 0/17 (0) | 0/17 (0) | 0/0 (0) |
| 5.11 | 0/18 (0) | 0/18 (0) | 0/0 (0) | |
| 6.17 | 0/2 (0) | 0/2 (0) | 0/0 (0) | |
| IE | 4.18 | 13/16 (81) | 7/16 (44) | 7/13 (53) |
| 5.60 | 12/12 (100) | 11/12 (92) | 11/12 (92) | |
| 5.72 | 3/3 (100) | 3/3 (100) | 3/3 (100) | |
| IAB/IE/IAB | 3.85 | 3/8 (38) | 0/8 (0) | 0/3 (0) |
| 4.81 | 0/16 (0) | 0/16 (0) | 0/0 (0) | |
| 4.90 | 4/8 (50) | 0/8 (0) | 0/4 (0) | |
| 5.77 | 2/4 (50) | 0/4 (0) | 0/2 (0) | |
| 5.81 | 10/19 (53) | 3/19 (16) | 3/10 (30) | |
| 8.50 | 13/23(57) | 3/23(13) | 3/13 (23) | |
| 8.60 | 3/4 (75) | 2/4(50) | 2/3 (66) | |
| IE/IAB/IE | 3.20 | 0/10 (0) | 0/10 (0) | 0/0 (0) |
| 3.60 | 4/20 (20) | 0/20 (0) | 0/4 (0) | |
| 3.98 | 9/17 (53) | 0/17(0) | 0/9 (0) | |
| 5.30 | 1/4 (25) | 0/4 (0) | 0/1(0) | |
| 6.00 | 5/16 (31) | 2/16 (13) | 2/5 (40) | |
| 8.20 | 2/2 (100) | 0/2 (0) | 0/2 (0) | |
| 8.40 | 16/20(80) | 7/20(35) | 7/16 (43) | |
| IAB/IE | 4.20 | 8/32 (25) | 0/32 (0) | 0/8 (0) |
| 4.70 | 7/20(35) | 0/20(0) | 0/7 (0) | |
| 6.00 | 8/18 (44) | 0/18 (0) | 0/8 (0) | |
| 6.23 | 2/22 (9) | 0/22(0) | 0/2 (0) | |
| 8.30 | 10/20(50) | 7/20(35) | 7/10 (70) | |
| 9.00 | 5/10 (50) | 4/10 (40) | 4/5 (80) | |
| IE/IAB | 4.60 | 8/27(30) | 0/27(0) | 0/8 (0) |
| 5.10 | 11/32 (34) | 0/32 (0) | 0/11 (0) | |
| 5.50 | 22/24 (92) | 7/24 (29) | 7/22 (31) | |
| 5.72 | 3/5 (60) | 2/5 (40) | 2/3 (66) | |
| 8.20 | 30/34(88) | 11/34(32) | 11/30 (36) | |
| 8.30 | 4/4 (100) | 2/4 (50) | 2/4 (50) |
Figure 4Oral exposure dose response of each virus examined during infection and dissemination in C. taeniopus.
Regression lines were generated for each virus for the purpose of visualizing the results. Graph A represents the percentage of infection at a given dose. The goodness of fit R2 values were 0.995, 0.421, 0.725, 0.340, and 0.617 for IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, respectively. Graph B represents the percentage of dissemination at a given dose, which yielded R2 values of 0.996, 0.535, 0.465, 0.820, and 0.500 for IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, respectively. Graph C represents the percentage of disseminated infection, which resulted in R2 values of 0.992, 0.606, 0.2397, 0.838, and 0.305 for IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, respectively.
Two-tailed Fisher's exact tests for infection rates of C. taeniopus.
| Virus | IAB | IE | IAB/IE/IAB | IE/IAB/IE | IAB/IE | IE/IAB |
| IAB | - | |||||
| IE | p<0.001 | - | ||||
| IAB/IE/IAB | p<0.001 | p<0.0001 | - | |||
| IE/IAB/IE | p<0.001 | p<0.0001 | NS | - | ||
| IAB/IE | p<0.001 | p<0.0001 | NS | NS | - | |
| IE/IAB | p<0.001 | p<0.0071 | p<0.0025 | p<0.0037 | p<0.0001 | - |
NS, not significant.
Initial midgut infection of 68U201 replicons in C. taeniopus.
| Replicon Group | # midguts examined | Average experimental titer (FU) | # infected midguts(%) | # cells infected | Average # cells infected |
| 68UGFP | 9 | 3.00 | 1/9 (11) | 2 | n/a |
| 68UGFP | 13 | 3.76 | 10/13 (77) | 3–21 | 6 |
| 68UGFP | 4 | 6.79 | 4/4 (100) | 50–323 | 130 |
| 68UGFP | 8 | 6.81 | 8/8 (100) | 27–393 | 128 |
| 68UGFP | 10 | 7.20 | 10/10 (100) | 535–1757 | 1012 |
n/a, not available.
Figure 5Sites of 68UGFP midgut infection in C. taeniopus (10×).
Replicons were observed to infect the anterior, mid, and posterior portions of the abdominal midgut at all doses of exposure.
Identity percentage between the IAB TrD and 68U201 genomes.
| 5′ UTR (nt) | nsP1(AA) | nsP2(AA) | nsP3(AA) | nsP4(AA) | 26S UTR (nt) |
| 93% | 95% | 94% | 69% | 94% | 86% |
| Capsid (AA) | E3 (AA) | E2 (AA) | 6K (AA) | E1 (AA) | 3′ UTR (nt) |
| 86% | 86% | 87% | 91% | 93% | 73% |